Table 2.
HIF-dependent genes in hypoxia adaptation in determining malignancy hallmarks.
| HIF-dependent genes | Adaptation phenotype | ROS effect | References |
|---|---|---|---|
| VEGFs and VEGFRs | Neoangiogenesis, repair | Indirect | [63–65] |
| TERT (telomerase) | ↑ telomere length and proliferative potential | Direct and indirect | [66–69] |
| Cyclin D1, cyclin D2 | Increased proliferation | Indirect | [70] |
| TERT; c-Myc, SOX2, OCT4, KLF4, Notch | Stem cell renewal, differentiated cell reprogramming | Indirect | [71, 72] |
| ABC transporter | Drug resistance | Indirect | [75–77] |
| ALDA, PGK, GLUT-1 | Changes in energy metabolism | Indirect | [61, 78] |
| PDGF, chemokine receptors | Motility and polarized migration | Indirect | [104, 105] |
| MMP9, MMPs | Integrity of basement membrane; invasiveness | Direct and indirect | [97–100] |
| Alarmin (DAMPs) receptors | NFκB activation; IRR gene express | Indirect | [80–82] |